A Smart Ring for Cuffless Blood Pressure to Reduce Health Disparities in People of Color
Project Number7R01EB034821-02
Former Number1R01EB034821-01
Contact PI/Project LeaderJAFARI, ROOZBEH Other PIs
Awardee OrganizationMASSACHUSETTS INSTITUTE OF TECHNOLOGY
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Hypertension is the most prevalent cardiovascular risk factor and disproportionately responsible for adverse
outcomes in African Americans. African Americans with hypertension are also more likely to be unaware of
elevated blood pressures, which further exacerbates complications of cardiovascular disease. Thus, detection
of accurate blood pressure in African Americans is a critical step towards alleviating hypertension disparate
outcomes. The objective of this project is to create an unobtrusive cuffless blood pressure monitor for
measurement and identification for masked hypertension in communities of color. Current state of the
technology that incorporates cuffs is cumbersome and does not allow for passive/frequent measurements. The
trends for cuffless solutions are primarily focused on photoplethysmography (PPG) which does not operate
well on darker skin tones and on participants with higher BMIs. This project leverages bioimpedance as a
sensing modality in the form of a finger-worn device, like smart rings. Our device provides robust and nearly
continuous bioimpedance readings, corresponding to blood volume and hemodynamic changes, that will be
translated to blood pressure using machine learning and AI algorithms. Bioimpedance does not have the
limitations of PPG; it is insensitive to varying skin tones and has deep penetration capabilities and therefore a
higher BMI (and a thicker layer of fat under the skin) does not impact the measurements. The principal focus of
our investigation is to gain insights into masked hypertension with the objective of capturing blood pressure
frequently during the day and at nighttime. Our proposed technology can help identify certain short-term
dynamics inclusive of variations of blood pressure and allows effective monitoring of response to medication
for African American in Atlanta, GA and African American and Latinx communities in College Station, TX. This
project incorporates two aims. Aim 1 intends to validate the smart ring technology that has been developed
at Texas A&M on African American and Latinx participants (N=60) with varying BMI in lab settings, with no
known pre-existing condition beyond obesity, in presence of various blood pressure maneuvers (cold pressor,
handgrip and exercise) and for three postures (supine, standing and sitting). Aim 2 expands the validation of
our technology in African American patients (N=144) with and without a history of hypertension in
Atlanta, GA in mixed lab and ambulatory settings with a unique focus to explore the reported phenomenon
of masked hypertension and to advance technology acceptance and social relevance in communities of color.
After nearly ten years of industrial and academic technology development to extract blood pressure indices
using PPG, to our knowledge, this effort for the first time addresses the limited effectiveness of PPG on darker
skin tones and those who have a higher BMI. The literature demonstrates the higher prevalence of
hypertension in African American communities and among those who have obesity, which further calls for BMI
independent technology development and validation.
Public Health Relevance Statement
PROJECT NARRATIVE
Continuous monitoring of blood pressure can help the early diagnosis of developing cardiovascular disease,
reveal short term blood pressure variations, and help the physician monitor the response to medication for
hypertensive patients. Current industrial and academic technology development for continuous cuffless blood
pressure has a primary focus on optical technologies which does not operate satisfactorily on darker skin tones
and those with higher BMI. Our proposed efforts will directly address this critical limitation through development
of a technology that will operate satisfactorily in communities of color.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAffectAfrican AmericanAfrican American populationAgeAmbulatory Blood Pressure MonitoringAnti-Hypertensive AgentsArtificial IntelligenceAtherosclerosisBlood PressureBlood Pressure MonitorsBlood VolumeBody mass indexCalibrationCardiovascular DiseasesCardiovascular systemCharacteristicsClinical ResearchColorCommunitiesDataDetectionDevelopmentDevicesEarly DiagnosisEffectivenessExerciseFatty acid glycerol estersFingersHigh PrevalenceHospitalsHumanHypertensionImaging technologyIndustrializationIntervention StudiesInvestigationLatinxLegal patentLightLiteratureMasksMeasurementMeasuresMelaninsMethodsModalityModelingMonitorNot Hispanic or LatinoObesityOpticsOrganParticipantPatient Self-ReportPatientsPatternPenetrationPharmaceutical PreparationsPhotoplethysmographyPhysiciansPhysiologic pulsePositioning AttributePosturePrevalencePulse PressureRecording of previous eventsReduce health disparitiesRegimenReportingResearchRisk FactorsScienceSignal TransductionSkinSleepSubgroupSupinationSupine PositionSystemTechnologyTexasTimeTissuesTranslatingValidationVariantWeightWorkadverse outcomeartificial intelligence algorithmattenuationblood pressure elevationcardiovascular risk factorclinical decision supportcohortcollegedesignexperiencehealth equityhemodynamicshigh body mass indexhypertensiveindexinginsightmachine learning algorithmmasked hypertensionmonitoring devicemultidisciplinarynoveloutcome disparitiespatient subsetspeople of colorpreventrecruitresponsesensorsexskin colorsmart ringsmart watchsocialtechnology developmenttechnology validationtrendwearable devicewearable sensor technology
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
001425594
UEI
E2NYLCDML6V1
Project Start Date
15-July-2023
Project End Date
30-April-2028
Budget Start Date
01-May-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$627,449
Direct Costs
$453,739
Indirect Costs
$173,710
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$627,449
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01EB034821-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01EB034821-02
Patents
No Patents information available for 7R01EB034821-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01EB034821-02
Clinical Studies
No Clinical Studies information available for 7R01EB034821-02
News and More
Related News Releases
No news release information available for 7R01EB034821-02
History
No Historical information available for 7R01EB034821-02
Similar Projects
No Similar Projects information available for 7R01EB034821-02